Published in Gastroenterol Jpn on February 01, 1991
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol (1993) 4.68
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest (1997) 2.11
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1994) 1.48
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut (2006) 1.30
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production. Rheumatol Int (2009) 1.13
NOD-like receptors and inflammation. Arthritis Res Ther (2008) 0.95
Expression of interleukin-6 by intestinal enterocytes. J Clin Pathol (1993) 0.95
β-Arrestin-1 deficiency protects mice from experimental colitis. Am J Pathol (2013) 0.93
Ameliorative effects of bombesin and neurotensin on trinitrobenzene sulphonic acid-induced colitis, oxidative damage and apoptosis in rats. World J Gastroenterol (2008) 0.89
Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase. Mediators Inflamm (2006) 0.89
A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease. Clin Exp Immunol (2006) 0.82
Heat-killed VSL#3 ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in rats. Int J Mol Sci (2013) 0.81
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome. J Inflamm (Lond) (2012) 0.80
Fermented Herbal Formulas KIOM-MA128 Ameliorate IL-6-Induced Intestinal Barrier Dysfunction in Colon Cancer Cell Line. Mediators Inflamm (2016) 0.78
The role of cytokines in inflammatory bowel disease. Mediators Inflamm (1994) 0.75
Gingko biloba extract (Ginaton) ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in mice via reducing IL-6/STAT3 and IL-23/IL-17. Int J Clin Exp Med (2015) 0.75
Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med (2000) 3.44
Nonsurgical, percutaneous transhepatic cholangiography--diagnostic significance in medical problems of the liver. Am J Dig Dis (1974) 3.09
CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med (2001) 3.05
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol (1997) 2.38
Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology (1999) 2.05
Serum vascular endothelial growth factor levels in various liver diseases. Dig Dis Sci (1998) 1.91
Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension. Am J Gastroenterol (1997) 1.85
Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J (1995) 1.68
Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology (2000) 1.65
Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy (1995) 1.55
A mutation of the Wilson disease protein, ATP7B, is degraded in the proteasomes and forms protein aggregates. Gastroenterology (2001) 1.53
Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ Res (2000) 1.52
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1994) 1.48
A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res (1993) 1.47
Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J Hepatol (2001) 1.46
Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis. Aliment Pharmacol Ther (2008) 1.46
Effect of posture-induced blood volume expansion on systemic and regional hemodynamics in patients with cirrhosis. J Hepatol (1997) 1.46
Unusual accumulation of glycogen in liver parenchymal cells in a patient with anorexia nervosa. Intern Med (1998) 1.46
Upright posture blunts postprandial splanchnic hyperemia in patients with cirrhosis and portal hypertension. J Gastroenterol (1999) 1.42
Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol (2005) 1.42
Effects of transcatheter splenic arterial embolization on portal hypertensive gastric mucosa. Am J Gastroenterol (1993) 1.41
ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6. Proc Natl Acad Sci U S A (2001) 1.41
Distinctive portal venographic pattern in patients with sclerotherapy resistant oesophageal varices. J Gastroenterol Hepatol (1996) 1.39
Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem (2001) 1.36
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors. Oncogene (2006) 1.34
Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology (1995) 1.34
Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut (1995) 1.31
Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol (1998) 1.31
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut (2006) 1.30
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology (1997) 1.30
Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med (2001) 1.28
A novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal vein. Cancer (1997) 1.26
Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol (1998) 1.25
Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology (1992) 1.24
Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Hepatology (2001) 1.20
Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion (1991) 1.20
Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scand J Gastroenterol (1998) 1.19
Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas. Hum Pathol (1999) 1.18
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C. Gut (2004) 1.17
Detection of hepatitis A antigen in human liver. Infect Immun (1982) 1.15
Empty virus-like particle-based enzyme-linked immunosorbent assay for antibodies to hepatitis E virus. J Med Virol (2000) 1.15
Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection. J Hepatol (1999) 1.12
Helicobacter pylori in the natural environment. Scand J Infect Dis (1999) 1.11
Meta-analysis: insulin resistance and sustained virological response in hepatitis C. Aliment Pharmacol Ther (2011) 1.11
Functional expression of mammalian myosin I beta: analysis of its motor activity. Biochemistry (1996) 1.10
Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest (1995) 1.08
Pneumomediastinum is a frequent but minor complication during esophageal endoscopic submucosal dissection. Endoscopy (2009) 1.08
Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology (1997) 1.07
A hinge at the central helix of the regulatory light chain of myosin is critical for phosphorylation-dependent regulation of smooth muscle myosin motor activity. J Biol Chem (1998) 1.07
Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training. Circulation (2000) 1.06
Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol (1998) 1.05
Pathology of chronic hepatitis C in children. Child Liver Study Group of Japan. Hepatology (1997) 1.05
Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-kappaB. J Neurosci (1999) 1.05
Comparison of carbohydrate structures of serum alpha-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis. Clin Chim Acta (1996) 1.05
Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology (1996) 1.04
Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol (1998) 1.04
Transcatheter arterial embolization for spontaneous rupture of hepatocellular carcinoma. Am J Gastroenterol (1986) 1.04
Ito cell contraction in response to endothelin-1 and substance P. Hepatology (1993) 1.04
Mechanical stretch induces TGF-beta synthesis in hepatic stellate cells. Eur J Clin Invest (2004) 1.03
Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant (2002) 1.01
ADP inhibits the sliding velocity of fluorescent actin filaments on cardiac and skeletal myosins. Circ Res (1994) 1.00
A histopathological study of alcoholics with chronic HCV infection: comparison with chronic hepatitis C and alcoholic liver disease. Liver (1995) 1.00
Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression. Alcohol Clin Exp Res (1996) 0.99
The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. J Viral Hepat (2005) 0.98
High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol (2000) 0.97
Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res (2001) 0.97
Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study. Aliment Pharmacol Ther (1998) 0.97
Local recurrence of colorectal tumors after endoscopic mucosal resection. Int J Oncol (1997) 0.97
Echo-Doppler measurements of portal vein and superior mesenteric artery blood flow in humans: inter- and intra-observer short-term reproducibility. J Gastroenterol Hepatol (1996) 0.97
Evaluation of magnetic resonance angiography on portosystemic collaterals in cirrhotic patients. Am J Gastroenterol (1997) 0.96
Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA. Cancer Res (1986) 0.96
Higher elimination rate of hepatitis C virus among women. J Viral Hepat (1996) 0.96
Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance. Biochem Biophys Res Commun (1995) 0.96
Phase I study of a novel recombinant human soluble thrombomodulin, ART-123. J Thromb Haemost (2004) 0.96
Monitoring of serum levels of HCV RNA in early phase of IFN therapy; as a predictive marker of subsequent response. Hepatogastroenterology (1998) 0.96